Clevor® (ropinirole ophthalmic solution)

Clevor is the first and only FDA-approved product for emesis induction in dogs.

Its selective active ingredient and unique ocular administration make the process easy and injection-free — all of which add up to a quicker, less stressful process for veterinarians, veterinary staff, the dog, and owners.

Clevor is ready to work when veterinarians — and their patients — need it. 

96% of users said the administration was easy or very easy in a study conducted with 100 dogs in the Clevor group.¹

Unlike other emetic options, Clevor does not need to be:

• Requested from a compounding pharmacy
• Resuspended or crushed to be administered
• Flushed from the eye after administration

Clevor is indicated for the induction of vomiting in dogs.

Ropinirole 30 mg/mL

Clevor is ready for immediate dosing with direct ocular administration. The number of drops is based on the dog’s body weight.

No complicated dose calculations or additional disposables, such as syringes or needles, required.

This product should be administered by a veterinary professional. Refer to the Dosage and Administration Section of the full prescribing information for dosing instructions.

Clevor is available in a convenient, ready-to-use dropper that provides one treatment for a dog weighing 4 pounds to 220.5 pounds.

Each box of Clevor contains five, single-use droppers packed in individual aluminum foil pouches.

Clevor is available from a licensed veterinarian. Veterinarians can contact their Vetoquinol representative or preferred distributor.

CLEVOR^® is indicated for the induction of vomiting in dogs.

IMPORTANT SAFETY INFORMATION: Do not use in dogs with central nervous system depression or seizures. Do not use in cases of ingestion of sharp foreign objects, corrosive agents (acids or alkalis), volatile substances or organic solvents. CLEVOR^® should not be administered in cases with corneal ulceration, ocular irritation, or ocular injury. Do not use when there is a known sensitivity to ropinirole or the inactive ingredients. ADVERSE REACTIONS MAY INCLUDE: Transient mild or moderate hyperemia of the eye, ocular discharge, protrusion of the 3rd eyelid and blepharospasm, transient mild lethargy and increased heart rate. Not recommended for use in breeding, pregnant or lactating dogs. CLEVOR^® has not been evaluated in dogs with heart or liver impairments or dogs younger than 4.5 months or less than 4 pounds. Dopamine antagonists, neuroleptics and other medicines with antiemetic properties may reduce the effectiveness of ropinirole. CLEVOR^® should be administered by a veterinary professional. Gloves and protective eyewear should be worn when administering. Not for use in humans. Keep out of reach of children. For full prescribing information, visit www.vetoquinolusa.com/clevor-info.

www.vetoquinolusa.com/clevor-info

1. Suokko, M., Saloranta, L., Lamminen, T., Laine, T., Elliott, J. (2020) Ropinirole eye drops induce vomiting effectively in dogs: a randomised, double-blind, placebo-controlled clinical study. Veterinary Record, Mar 7;186(9):283.

CLEVOR^® is a trademark of Orion Corporation. It is manufactured by Orion Corporation and distributed by Vetoquinol USA under license from Orion Pharma Animal Health.